AR20.5
AR20.5 is a human monoclonal antibody (mAb) targeting MUC1. AR20.5 increases the number of activated CD8 T cells, CD3+CD4−CD8− (DN) T cells, and mature dendritic cells in pancreatic tumor-bearing mice. AR20.5 can be used in anti-pancreatic cancer immunity research[1].
Product Specifications
UNSPSC
12352203
Target
Mucin
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[AR20.5]
References & Citations
[1]Mehla K, et al. Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunol Immunother. 2018 Mar;67 (3) :445-457.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
T1030-01A 100 µg
Tau (Tau Protein, Microtubule-associated Protein Tau, MAPT, Neurofibrillary Tangle Protein, Paired Helical Filament-tau, PHF-tau, MAPTL, MTBT1)
Sign In for Pricing
View Details N5379-50G-ML650 100 µL
NQO1 (NAD (P) H Dehydrogenase Quinone 1, Azoreductase, Cytochrome b-5 Reductase, DHQU, Diaphorase (NADH/NADPH) (Cytochrome b-5 Reductase), Diaphorase 4, DIA4, Dioxin Inducible 1, DT Diaphorase, DTD, Menadione Reductase, NAD (P) H Menadione Oxidoreductase 1 Dioxin Inducible, NAD (P) H: Menadione Oxidoreductase 1 Dioxin Inducible 1, NMOR1, NMORI, NAD (P) H: Quinone Acceptor Oxidoreductase Type 1, NAD (P) H: Quinone Oxidoreductase 1, Phylloquinone Reductase, Quinone Reductase 1, QR1) (MaxLight 650) discontinued
Sign In for Pricing
View Details 